secwatch.observer — SEC 8-K summary
======================================

Issuer:     Biomea Fusion, Inc. (BMEA)
CIK:        0001840439
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001193125-25-142830
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Biomea Fusion prices $40M public offering of 19.45M shares and warrants at $2.00/unit
--------------------------------------------------------------------------------

- Offering of 19.45M common shares and 19.45M accompanying warrants; 550K pre-funded warrants for certain investors.
- Combined price $2.00 per share + warrant, $1.9999 per pre-funded warrant + warrant; gross proceeds ~$40M.
- Common stock warrants exercisable at $2.50/share, expire 18 months from issuance; pre-funded warrants at $0.0001.
- Expected close June 20, 2025; net proceeds ~$37.1M ($42.7M if underwriter option exercised in full).
- Jefferies acting as sole book-runner; proceeds for general corporate purposes and clinical development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840439/000119312525142830/0001193125-25-142830-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840439/000119312525142830/d44604d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-142830

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer